Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

262.75 -1.32 (-0.50%)
Official Closing Price Updated: 4:15 PM EDT, Apr 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,082,722
Open 265.64
Bid (Size) 262.58 (2)
Ask (Size) 263.05 (1)
Prev. Close 264.07
Today's Range 262.58 - 265.92
52wk Range 211.71 - 329.72
Shares Outstanding N/A
Dividend Yield 3.24%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick
Amgen's Tezspire shows promising COPD trial results and potential market expansion beyond asthma. Comparison with Dupixent reveals significant benefits for eosinophil counts ≥150 cells/μL and ≥300... 
Via Benzinga
Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga

Performance

YTD
-11.65%
-11.65%
1 Month
-3.01%
-3.01%
3 Month
-13.59%
-13.59%
6 Month
-7.35%
-7.35%
1 Year
+6.77%
+6.77%

More News

Read More
Coming FDA Approvals Could Send These 3 Drug Stocks Soaring
Via InvestorPlace
Exposures Product Safety
Sell These 3 Blue-Chip Stocks Before the Next Earnings Stumble
Via InvestorPlace
Topics Stocks
Exposures US Equities
Can This High-Yield Dividend Stock Keep Beating the S&P 500?
Via The Motley Fool
Topics Stocks
Exposures US Equities
Looking At Amgen's Recent Unusual Options Activity
Via Benzinga
Is Amgen Stock a Buy?
Via The Motley Fool
7 Analysts Have This To Say About Amgen
Via Benzinga
Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever
Via The Motley Fool
The 3 Best Biotech Stocks to Buy Now: Q2 Edition
Via InvestorPlace
3 Stocks to Buy Low Today With High Hopes for Tomorrow
Via InvestorPlace
Amgen, Shell And More On CNBC's 'Final Trades'
Via Benzinga
Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024?
Via InvestorPlace
Amgen Unusual Options Activity For April 02
Via Benzinga
Amgen Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
3 High-Growth Biotech Stocks Investors Shouldn’t Sleep On in April
Via InvestorPlace
The 3 Most Undervalued S&P 500 Stocks to Buy in April 2024
Via InvestorPlace
Topics Economy Stocks
Exposures Economy US Equities
2 Biotech Stocks to Buy Hand Over Fist in April
Via The Motley Fool
3 Stocks to Consider Adding to Your Retirement Portfolio in April
Via The Motley Fool
Topics Retirement
Exposures Pension
Is Amgen The Rare Biotech With A Safe Dividend?
Via Talk Markets
Biotech Sector Nears Breakout: Will it Outperform in Q2?
Via MarketBeat
Topics ETFs
5 Healthcare Stocks to Buy for 2024
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Redditors Identify 'Best Undervalued Stocks' For 2024
Via Benzinga
Amgen's Diversified Portfolio To Drive Long-Term Growth, Though Uncertainties Loom, Analyst Says
Via Benzinga
7 Stocks That Will Drive the Weight Loss Drugs Market
Via MarketBeat
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.